Gapping down
In reaction to earnings/guidance:
- MLHR -6.2%, FDS -0.9%
Other news:
- DMAC -26.8% (reports interim results from phase 2 REDUX Study in CKD)
- SNSE -10.4% (announces prioritization of next-generation immunophage platform, monoclonal antibody and nanobody programs)
- ALGS -7.3% (stock offering)
- KYMR -4.6% (stock offering)
- BTRS -2.7% (stock offering)
- TIPT -2.6% (files for $500 mln mixed securities shelf offering)
- NTLA -2.5% (commences $400 mln common stock offering)
- XPO -1.9% (prices offering of 5 mln shares of common stock at $138.00 per share)
- LAZR -1.2% (stock offering)
- ZNTL -1% (prices offering of 3.1 mln shares of common stock at $48.50 per share)
Analyst comments:
- CVNA -2.1% (downgraded to Neutral from Overweight at Piper Sandler)
- BLI -2% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- PTR -1.2% (downgraded to Neutral from Buy at UBS)
- TWO -1.2% (downgraded to Neutral from Outperform at Credit Suisse)
- FOXA -1.1% (downgraded to Neutral from Buy at Guggenheim)